UK cancer fund was poor value and may have caused patient suffering

LONDON (Reuters) – A special U.K. Cancer Drugs Fund (CDF) set up in 2010 spent over 1.2 billion pounds ($1.55 bln) but failed to deliver value for patients or society and may have caused unnecessary suffering, an analysis has found.


Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *